Case Study

Accelerating IND Filing for a Global Biosimilar Developer

Confidential Biosimilar Sponsor Pharmaceuticals & Biopharmaceuticals

Sponsor needed bioanalytical method validation and TK sample analysis completed in under 12 weeks to meet IND submission window.

Parallel-tracked method development and validation across two analytical teams. Built a study-specific LIMS workflow for real-time sponsor visibility.